Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating LiveSpo X-Secret Probiotic Spray for Vaginitis
NCT06165354Completed
- Sponsor
- AnaBio Technologies
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of LiveSpo X-secret in vaginitis (2 arms), sponsored by AnaBio Technologies. Primary endpoint: Percentage of patients with free and/or reduced gynecological infection symptoms at Day 28. Started Dec 2023; status: completed.
02
Drugs
LiveSpo X-secret
03
Conditions
vaginitis
Beyond the preview
Go deeper on NCT06165354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06165354.